Ann Yellowlees

Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study)

T. Hugh Jones, Stefan Arver, Hermann M. Behre et al. · Diabetes Care · 2011 · 534 citations · Full text

Phase III Randomized Trial of Doxorubicin and Docetaxel Versus Doxorubicin and Cyclophosphamide As Primary Medical Therapy in Women With Breast Cancer: An Anglo-Celtic Cooperative Oncology Group Study

T.R. Jeffry Evans, Ann Yellowlees, E. Foster et al. · Journal of Clinical Oncology · 2005 · 173 citations

GnRH agonist for protection against ovarian toxicity during chemotherapy for early breast cancer: the Anglo Celtic Group OPTION trial

Robert Leonard, Douglas Adamson, Gianfilippo Bertelli et al. · Annals of Oncology · 2017 · 149 citations · Full text

Breast Oncology, Early Breast Cancer, Medicine +11

Conventional Adjuvant Chemotherapy Versus Single-Cycle, Autograft-Supported, High-Dose, Late-Intensification Chemotherapy in High-Risk Breast Cancer Patients: A Randomized Trial

Renaud Léonard, M. Lind, C.J. Twelves et al. · JNCI Journal of the National Cancer Institute · 2004 · 58 citations · Full text

Anglo-Celtic IV: First results of a UK National Cancer Research Network randomized phase III pharmacogenetic trial of weekly compared to 3 weekly paclitaxel in patients with locally advanced or metastatic breast cancer (ABC)

Mark Verrill, J. Lee, David Cameron et al. · Journal of Clinical Oncology · 2007 · 46 citations

Breast Oncology, Total Dose, Weekly Paclitaxel +21